申请人:Roussel Uclaf
公开号:US05308865A1
公开(公告)日:1994-05-03
A compound selected from the group consisting of a compound of the formula ##STR1## wherein R.sub.1 is selected from the group consisting of ##STR2## R.sub.13, R.sub.14 and R.sub.15 are individually selected from the group consisting of hydrogen, halogen and alkyl of 1 to 3 carbon atoms, n is an integer from 1 to 3, R.sub.2 is hydrogen or alkyl of 1 to 3 carbon atoms, R.sub.3, R.sub.4 R.sub.5, R.sub.6 and R.sub.7 are individually selected from the group consisting of hydrogen, halogen, --NO.sub.2, --CN, alkyl, alkylthio and alkoxy of 1 to 6 carbon atoms, alkylcarbonyl of 2 to 6 carbon atoms, cycloalkyl of 3 to 6 carbon atoms, ##STR3## m is 0, 1, 2 or 3, n is 1, 2 or 3; Hal, Hal.sub.1, Hal.sub.2 and Hal.sub.3 are individually halogen and ##STR4## R.sub.8, R.sub.9, R.sub.10, R.sub.11 and R.sub.12 are individually any of the groups defined above for R.sub.3, R.sub.4, R.sub.5, R.sub.6 and R.sub.7 or R.sub.4 and R.sub.5 together form --O--CH.sub.2 --O-- and their non-toxic, pharmaceutically acceptable base addition salts having anti-inflammatory activity.
从以下化合物组中选择化合物:##STR1## 其中R.sub.1是从以下组中选择的:##STR2## R.sub.13,R.sub.14和R.sub.15分别从氢,卤素和1至3个碳原子的烷基中选择,n是1至3的整数,R.sub.2是氢或1至3个碳原子的烷基,R.sub.3,R.sub.4,R.sub.5,R.sub.6和R.sub.7分别从氢,卤素,--NO.sub.2,--CN,1至6个碳原子的烷基,烷基
硫醚和烷氧基,2至6个碳原子的烷基羰基,3至6个碳原子的环烷基,##STR3## m为0、1、2或3,n为1、2或3;Hal,Hal.sub.1,Hal.sub.2和Hal.sub.3分别为卤素和##STR4## R.sub.8,R.sub.9,R.sub.10,R.sub.11和R.sub.12分别为R.sub.3,R.sub.4,R.sub.5,R.sub.6和R.sub.7中定义的任何一组,或R.sub.4和R.sub.5共同形成--O--CH.sub.2--O--,以及其非毒性、药用的可接受的碱盐,具有抗炎活性。